Recombinant Amia calva Cytochrome c oxidase subunit 1 (mt-co1)

Basic Research Questions

• What is MT-CO1 and what is its functional significance in cellular metabolism?

  MT-CO1, also known as mitochondrially encoded cytochrome c oxidase I, is an integral component of the mitochondrial electron transport chain. Encoded by the MT-CO1 gene, it functions within complex IV on the mitochondrial inner membrane. MT-CO1 primarily catalyzes the transfer of electrons to oxygen, producing water and facilitating ATP synthesis, which is essential for cellular energy metabolism . This protein contains multiple functional domains that enable copper ion binding and heme binding activities, which are critical for its oxidoreduction-driven active transmembrane transporter functions . The significance of MT-CO1 extends beyond basic metabolism, as dysfunction of this protein has been associated with various pathological conditions including neurodegenerative disorders, muscle diseases, and cardiomyopathies .

• What experimental techniques commonly employ recombinant MT-CO1?

  Recombinant MT-CO1 is utilized in multiple experimental techniques across molecular and cellular biology research. Primary applications include:

  • Immunological assays: Recombinant MT-CO1 serves as an antigen for antibody production and validation. It is used in ELISA, immunohistochemistry (IHC), and immunofluorescence (IF) applications to detect and quantify MT-CO1 expression in various tissues and cell types .

  • Enzymatic activity assays: The protein is employed in functional studies to measure cytochrome c oxidase activity, particularly in investigating mitochondrial respiratory chain efficiency.

  • Protein-protein interaction studies: Recombinant MT-CO1 is used to identify binding partners within the respiratory complex and other potential interactors.

  • Structural biology: The purified protein facilitates structural characterization of mitochondrial respiratory components.

  The validation data from MT-CO1 antibodies shows successful application in multiple techniques, including immunohistochemistry of human ovarian and prostate cancer tissues, and immunofluorescent analysis of HeLa cells .

• How does MT-CO1 contribute to species identification through DNA barcoding?

  MT-CO1 serves as a standard genetic marker for DNA barcoding due to its consistent sequence divergence patterns across species. The process involves:

  1. Isolation of mitochondrial DNA from tissue samples

  2. PCR amplification of the MT-CO1 gene region

  3. Sequencing of the amplified product

  4. Comparative analysis against reference databases

  This method is particularly valuable because MT-CO1 exhibits low intraspecific variation (within species) but high interspecific variation (between species), creating a "barcode gap" that enables reliable differentiation . The phylogenetic analysis typically employs computational methods such as:

  • Calculation of genetic distances using the Kimura 2 Parameter method

  • Construction of Neighbor Joining trees to visualize relationships

  • Maximum likelihood analysis for evolutionary relationship assessment

  DNA barcoding through MT-CO1 offers greater reliability compared to traditional morphological identification methods, particularly when dealing with closely related species or specimens with ambiguous physical characteristics .

• What characterizes the structure and expression pattern of MT-CO1?

  MT-CO1 is characterized by a complex protein structure that includes multiple transmembrane domains and cofactor binding sites essential for its electron transport function. In model organisms like zebrafish (Danio rerio), MT-CO1 exhibits specific expression patterns across various tissues and developmental stages . The protein is localized to the mitochondrial inner membrane and forms part of respiratory chain complex IV .

  Expression studies in zebrafish have documented MT-CO1 presence in:

  • Female and male organisms

  • Gill tissues

  • Liver

  • Musculature system

  The protein is predicted to enable multiple molecular functions, including:

  • Copper ion binding

  • Heme binding

  • Oxidoreduction-driven active transmembrane transport

  MT-CO1 has been shown to respond to environmental stressors, specifically acting upstream of or within response pathways to cadmium ion and methylmercury exposure , indicating its potential role in cellular stress responses beyond its primary function in oxidative phosphorylation.

Advanced Research Questions

• How does downregulation of MT-CO1 contribute to radioresistance in cancer cells?

  Downregulation of MT-CO1 has been identified as a mechanism leading to radioresistance in esophageal squamous cell carcinoma. This process involves multiple cellular pathways:

  MT-CO1 downregulation inhibits the apoptotic response normally triggered by radiation through disruption of the caspase cascade activation pathway. In a study using transposon-based gene screening to identify radioresistant genes, MT-CO1 was detected in three radioresistant colonies . The research demonstrated that:

  • MT-CO1-downregulated cells showed significantly higher survival rates after irradiation compared to parent cells (28.7% vs. 10.5% at day 9 after 5-Gy irradiation, P<0.001)

  • The activity of cytochrome c and caspase-3 following irradiation was significantly lower in MT-CO1-downregulated radioresistant cells

  • While survival rates continued to decrease in parent cells after irradiation, they increased in MT-CO1-downregulated cells at day 9

  This mechanism suggests that MT-CO1 functions as a sensitivity factor for radiation therapy, and its downregulation may represent a cellular adaptation that increases cancer cell survival following radiotherapy . These findings have significant implications for developing strategies to overcome radioresistance in cancer treatment.

• What methodologies are most effective for investigating MT-CO1 variants and their clinical significance?

  Investigating MT-CO1 variants requires a comprehensive methodological approach that integrates molecular, cellular, and clinical analyses:

  Molecular characterization:

  • Next-generation sequencing of mitochondrial DNA to identify variants

  • Site-directed mutagenesis to recreate variants in experimental systems

  • Computational prediction of variant effects using tools like ACMG guidelines

  Functional assessment:

  • Oxygen consumption measurements to quantify respiratory chain function

  • Cytochrome c release assays to evaluate apoptotic potential

  • Measurement of ATP production to assess energetic consequences

  Clinical correlation:

  • Case-control studies comparing variant frequencies in patient cohorts

  • Family studies to establish inheritance patterns

  • Correlation with clinical phenotypes

  An example of this approach is seen in the clinical evaluation of the NC_012920.1(MT-CO1):m.7362G>A variant, which was classified as "uncertain significance" for Leigh syndrome . The classification utilized modified ACMG guidelines and specifically noted the BP4 evidence code, suggesting multiple layers of analysis to determine potential pathogenicity .

• How can researchers differentiate between the functional impacts of various MT-CO1 mutations?

  Differentiating functional impacts of MT-CO1 mutations requires systematic approaches that combine:

  Biochemical assays:

  • Enzyme activity measurements comparing wild-type and mutant proteins

  • Spectroscopic analyses to assess heme incorporation and electron transfer capabilities

  • Protein stability assessments to determine if mutations affect protein folding or degradation rates

  Cellular models:

  • Cybrid cell lines incorporating patient-derived mitochondria with specific mutations

  • CRISPR-engineered cell lines with defined mutations

  • Measurement of cellular consequences including ATP production, ROS formation, and apoptotic sensitivity

  Structural biology approaches:

  • Comparative structural modeling based on known cytochrome c oxidase structures

  • Identification of how mutations might affect critical domains or interaction surfaces

  For example, the variant NC_012920.1(MT-CO1):m.7362G>A results in a p.Glu487Lys substitution that requires careful assessment of its impact on protein function . Mutations affecting copper binding sites or proton channels would be expected to have more severe functional consequences than those in less conserved regions of the protein.

• What experimental designs best capture the role of MT-CO1 in the mitochondrial apoptotic pathway?

  Optimal experimental designs for investigating MT-CO1's role in apoptosis include:

  Genetic manipulation approaches:

  • RNA interference (siRNA/shRNA) targeting MT-CO1

  • CRISPR-Cas9 mediated genetic modification

  • Overexpression systems using recombinant MT-CO1

  Apoptotic pathway analysis:

  • Measurement of cytochrome c release from mitochondria

  • Caspase activity assays (particularly caspase-3)

  • TUNEL assays to detect DNA fragmentation

  • Annexin V/PI staining for flow cytometric analysis of apoptotic populations

  Stress response evaluations:

  • Radiation exposure (as demonstrated in esophageal cancer studies)

  • Chemical inducers of apoptosis (e.g., staurosporine, etoposide)

  • Hypoxia/reoxygenation challenges

  The study of MT-CO1 downregulation in radioresistant cancer cells effectively employed this multifaceted approach, demonstrating that MT-CO1 downregulation resulted in:

  • Reduced cytochrome c activity after irradiation

  • Decreased caspase-3 activation

  • Significantly increased cell survival following radiation exposure

  These findings established a direct link between MT-CO1 expression levels and apoptotic potential, highlighting the importance of comprehensive experimental designs that capture multiple aspects of the apoptotic response.

• How do sequence variations in Amia calva MT-CO1 compare with other species for evolutionary and phylogenetic studies?

  Sequence analysis of Amia calva MT-CO1 reveals important evolutionary relationships when compared with other species:

  The Amia calva MT-CO1 partial protein sequence (188 amino acids) contains highly conserved functional domains common to cytochrome c oxidase subunit 1 across species . Comparative analysis typically involves:

  • Multiple sequence alignment to identify conserved and variable regions

  • Calculation of sequence similarity percentages between species

  • Identification of signature sequences that may be unique to particular lineages

  • Construction of phylogenetic trees using maximum likelihood or Bayesian methods

  DNA barcoding studies utilizing MT-CO1 sequences employ computational analysis methods such as:

  • Calculation of genetic distances using the Kimura 2 Parameter method

  • Construction of Neighbor Joining trees to visualize relationships

  • Analysis of branch support through bootstrap testing

  These approaches allow researchers to place Amia calva (a primitive ray-finned fish) in its proper evolutionary context within vertebrate phylogeny, and to understand how structural and functional constraints have shaped the evolution of this essential respiratory protein across different lineages.

• What are the methodological considerations for using MT-CO1 antibodies in complex tissue samples?

  Utilizing MT-CO1 antibodies for research in complex tissue samples requires careful methodological considerations:

  Antibody selection and validation:

  Several MT-CO1 antibodies are commercially available with different applications and species reactivity. Researchers should select antibodies validated for their specific application and target species:

  Code	Product Name	Species Reactivity	Application
  CSB-PA015072LA01HU	MT-CO1 Antibody	Human	ELISA, IHC, IF
  CSB-PA015072LB01HU	MT-CO1 Antibody, HRP conjugated	Human	ELISA
  CSB-PA015072LD01HU	MT-CO1 Antibody, Biotin conjugated	Human	ELISA
  CSB-PA868168XA01DIL	mt-co1 Antibody	Danio rerio (Zebrafish)	ELISA, WB

  Optimization of protocols:

  • Appropriate dilution determination (e.g., 1:100 for IHC and IF applications as demonstrated in validated data)

  • Antigen retrieval method selection for formalin-fixed tissues

  • Blocking optimization to reduce background

  • Incubation time and temperature adjustments

  Controls and specificity verification:

  • Positive control tissues with known MT-CO1 expression

  • Negative controls omitting primary antibody

  • Peptide competition assays to confirm specificity

  • Correlation with other mitochondrial markers

  Quantification approaches:

  • Digital image analysis for IHC quantification

  • Fluorescence intensity measurement for IF applications

  • Normalization to appropriate housekeeping proteins or total protein content

  Successful application of MT-CO1 antibodies has been demonstrated in human ovarian and prostate cancer tissues using immunohistochemistry and in HeLa cells using immunofluorescence , providing a methodological foundation for researchers working with this protein.